Literature DB >> 1892359

Medullary catecholaminergic neurons in the normal human brain and in Parkinson's disease.

C B Saper1, D M Sorrentino, D C German, S de Lacalle.   

Abstract

Parkinson's disease is thought to cause degeneration of melanin-pigmented catecholaminergic neurons throughout the brainstem, but little quantitative information is available on the fate of catecholaminergic neurons associated with the dorsal vagal complex or medullary reticular formation. We therefore examined these neurons in the normal human medulla and in the brains of patients with Parkinson's disease, using both a melanin stain and immunohistochemical methods with an antiserum against tyrosine hydroxylase. The greatest numbers of catecholaminergic neurons in the ventrolateral reticular formation (A1/C1 group) were located in the far rostral medulla, whereas the largest populations of catecholaminergic cells in the dorsal vagal complex (A2/C2 group) were found at the level of the area postrema. No loss of cells was observed in the A1/C1 group in the parkinsonian brains. In contrast, the A2/C2 group showed moderate loss of neurons, most marked at the level of the area postrema. This difference was entirely due to the loss of neurons in the medial component of the A2 group, a population that normally is only lightly pigmented, while the heavily pigmented neurons in the ventral and intermediate components of the A2 complex were unaffected. Parkinson's disease causes degeneration only of selected populations of medullary catecholaminergic neurons, without apparent relationship to the extent of melanin pigmentation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1892359     DOI: 10.1002/ana.410290602

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  17 in total

Review 1.  The role of calcium and mitochondrial oxidant stress in the loss of substantia nigra pars compacta dopaminergic neurons in Parkinson's disease.

Authors:  D J Surmeier; J N Guzman; J Sanchez-Padilla; P T Schumacker
Journal:  Neuroscience       Date:  2011-08-25       Impact factor: 3.590

Review 2.  Calcium, bioenergetics, and neuronal vulnerability in Parkinson's disease.

Authors:  D James Surmeier; Paul T Schumacker
Journal:  J Biol Chem       Date:  2012-10-19       Impact factor: 5.157

3.  Subcellular localization of nicotinamide adenine dinucleotide phosphate oxidase subunits in neurons and astroglia of the rat medial nucleus tractus solitarius: relationship with tyrosine hydroxylase immunoreactive neurons.

Authors:  M J Glass; J Huang; M Oselkin; M J Tarsitano; G Wang; C Iadecola; V M Pickel
Journal:  Neuroscience       Date:  2006-10-04       Impact factor: 3.590

Review 4.  Physiological phenotype and vulnerability in Parkinson's disease.

Authors:  D James Surmeier; Jaime N Guzman; Javier Sanchez; Paul T Schumacker
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

Review 5.  The pathology roadmap in Parkinson disease.

Authors:  D James Surmeier; David Sulzer
Journal:  Prion       Date:  2013-01-01       Impact factor: 3.931

Review 6.  Brainstem in multiple system atrophy: clinicopathological correlations.

Authors:  Eduardo E Benarroch
Journal:  Cell Mol Neurobiol       Date:  2003-10       Impact factor: 5.046

Review 7.  Calcium, cellular aging, and selective neuronal vulnerability in Parkinson's disease.

Authors:  D James Surmeier; Jaime N Guzman; Javier Sanchez-Padilla
Journal:  Cell Calcium       Date:  2010-01-06       Impact factor: 6.817

8.  Topodiagnostic investigations on the sympathoexcitatory brain stem pathway using a new method of three dimensional brain stem mapping.

Authors:  J J Marx; G D Iannetti; A Mika-Gruettner; F Thoemke; S Fitzek; G Vucurevic; P P Urban; P Stoeter; G Cruccu; H C Hopf
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-02       Impact factor: 10.154

9.  Quantitative assessment of non-motor fluctuations in Parkinson's disease using the Non-Motor Symptoms Scale (NMSS).

Authors:  Alexander Storch; Christine B Schneider; Lisa Klingelhöfer; Per Odin; Gerd Fuchs; Wolfgang H Jost; Pablo Martinez-Martin; Rainer Koch; Heinz Reichmann; K Ray Chaudhuri; Georg Ebersbach
Journal:  J Neural Transm (Vienna)       Date:  2015-08-12       Impact factor: 3.575

Review 10.  Neuronal vulnerability, pathogenesis, and Parkinson's disease.

Authors:  David Sulzer; D James Surmeier
Journal:  Mov Disord       Date:  2012-07-12       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.